A CRISPR/Cas13a-based and hybridization chain reaction coupled evanescent wave biosensor for SARS-CoV-2 gene detection
The Analyst · 2025
DOI: 10.1039/d4an01584c ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2025. Verfasst von Yang Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China. Hauptthemen laut MEDLINE: Biosensing Techniques, SARS-CoV-2, CRISPR-Cas Systems, COVID-19. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
The CRISPR/Cas13a-HCR evanescent wave fluorescence biosensing platform is used for the high-sensitivity detection of the SARS-CoV-2 gene in a short time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of NBC Protection for Civilian, Beijing 102205, China.
Zitieren
APA
Li, Y., Zhao, Y., Yi, Z., & Han, S. (2025). A CRISPR/Cas13a-based and hybridization chain reaction coupled evanescent wave biosensor for SARS-CoV-2 gene detection. The Analyst. https://doi.org/10.1039/d4an01584c
Vancouver
Li Y, Zhao Y, Yi Z, Han S. A CRISPR/Cas13a-based and hybridization chain reaction coupled evanescent wave biosensor for SARS-CoV-2 gene detection. The Analyst. 2025. doi:10.1039/d4an01584c
BibTeX
@article{Li2025,
author = {Li, Yang and Zhao, Yikan and Yi, Zhihao and Han, Shitong},
title = {A CRISPR/Cas13a-based and hybridization chain reaction coupled evanescent wave biosensor for SARS-CoV-2 gene detection},
journal = {The Analyst},
year = {2025},
doi = {10.1039/d4an01584c}
}
EUVIMED